WHO Calls for Urgent Global Action as Cancer Cases Expected to Nearly Double by 2050

WHO Calls for Urgent Global Action as Cancer Cases Expected to Nearly Double by 2050

The World Health Organization (WHO) warned on July 8, 2026, that annual cancer cases are projected to rise to nearly 35 million by 2050 without urgent global intervention. Currently, the disease claims more than 26 000 lives every day, with an estimated 20.6 million new cases and close to 10 million deaths annually.

According to the WHO Global Status Report on Cancer 2026, developed jointly with the International Agency for Research on Cancer (IARC), cancer is the second leading cause of death worldwide, trailing only cardiovascular disease. The report indicates that 92% of the world's population will be affected by cancer at some point, either through a personal diagnosis or that of a close family member.

Widening Global Inequities

The report highlights a stark divide in survival rates based on national wealth. For women diagnosed with breast cancer, the 5-year survival rate is 87% in high-income countries, but drops to about 42% in low-income countries. Some data suggests these figures are 85% for wealthy nations and around 40% for poorer ones.

Access to essential care remains limited. Fewer than one in three countries include cancer care in their universal health coverage packages, and minimal treatment is available in just 39% of countries. This disparity extends to medication; the availability of the top 20 priority cancer medicines ranges from 68% to 94% in high-income countries, compared to just 9% to 54% in low- and lower-middle-income nations.

"Cancer is a deeply personal disease that touches nearly all of us. But whether a person survives cancer should never depend on where they were born or what they earn,”

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, via who.int

Dr Tedros Adhanom Ghebreyesus added that the documented inequities are the consequence of choices and can be reversed through unified action.

Regional Burdens and Risk Factors

The impact of cancer varies significantly by geography. In 2024, Asia bore the largest share of the burden, accounting for 50.7% of all cases and 56.5% of deaths. Europe contributed 21% of global cases and 20% of deaths, despite representing only about 9% of the global population. In Latin America and the Caribbean, 2024 estimates show nearly 1.5 million new cases and more than 750,000 deaths.

Lung cancer is the leading cause of cancer death globally. For men, the most common types include lung, prostate, and colorectal cancers; for women, breast, lung, and colorectal cancers account for a substantial share.

Nearly four in ten cases are linked to preventable factors, including:

• Tobacco and alcohol use
• Infections such as human papillomavirus (HPV), hepatitis B and C, and helicobacter pylori
• High body mass index, obesity, and insufficient physical activity
• Unhealthy diets and air pollution

Dr Elisabete Weiderpass, Director of the IARC, noted that while some rates have fallen where prevention policies exist, progress is too slow. She warned that the cancer profile is evolving, increasingly driven by pollution and obesity.

Social and Financial Devastation

Beyond medical symptoms, cancer is described in the report as a leading driver of medical bankruptcy. A first-ever WHO survey of affected individuals found that at least 45% experience financial hardship and more than half report mental health challenges. Additionally, more than half of patients and their families face catastrophic health care costs.

Caregivers are also heavily impacted, with nearly all reporting strain, including social isolation and unpaid services.

"Cancer is not just a medical diagnosis – it profoundly, indefinitely affects every aspect of a person’s life, and their family's as well,”

Clarissa Schilstra, childhood cancer survivor and WHO survey lead, via who.int

Progress and Strategic Shifts

The WHO noted some positive trends since 2010, including a 27% decline in tobacco use and an increase in national cancer control plans, which now exist in 82% of countries, up from 50%. In high-income countries, 74% of women have been screened for cervical cancer. registered clinical trials grew at an annual rate of 7.3% between 2005 and 2021.

Despite these gains, WHO expert André Ilbawi stated that many people are still being left behind while global debates focus on new technologies and treatment options.

The report concludes that the primary gap is no longer one of knowledge, but a gap between what we know and what we do. To combat this, the WHO is calling for a people-centred, holistic approach that integrates cancer services into universal health coverage and strengthens social protections for affected families.